VANCOUVER, British Columbia — February 7, 2026 — Leads & Copy — Cannabix Technologies Inc. is planning a non-brokered private placement of a minimum of 1,000,000 and up to 2,000,000 units at a price of CDN$0.50 each, according to a news release.
The offering could generate gross proceeds of at least CDN$500,000 and up to CDN$1,000,000 for the company. Each unit will consist of one common share and one non-transferable common share purchase warrant.
Each warrant will allow the holder to acquire one share at an exercise price of CDN$0.65 per share for 24 months from the date of issuance. The warrants are subject to an acceleration clause.
If the closing price of the shares on the Canadian Securities Exchange (or other exchange the shares are traded on) is at or above CDN$0.75 per share for 10 consecutive trading days, Cannabix may accelerate the expiry date of the warrants. The company would provide notice via news release, and the warrants would expire 30 calendar days after the notice date.
Company insiders may acquire units in the offering, which would be considered a “related party transaction” under Multilateral Instrument 61-101. All securities issued to insiders will have the same terms and conditions as those issued to other subscribers.
The company confirms that no proceeds from the offering will be used to repay insider debt, pay compensation to insiders, or fund transactions involving insiders or their affiliates.
The participation of insiders is expected to be exempt from formal valuation and minority shareholder approval requirements, as the fair market value of the units subscribed for by insiders and the consideration paid would not exceed 25% of the company’s market capitalization.
Cannabix plans to use the net proceeds from the financing for manufacturing inventory and labor, general and administrative expenses (including investor relations), and unallocated working capital.
An offering document related to the offering is available under the company’s profile at www.sedarplus.ca and at cannabixtechnologies.com. The offering is available to purchasers resident in Canada (excluding Quebec), the United States, or countries other than the United States and Canada. Shares issued under the offering will not be subject to resale restrictions.
An investor of the company holds a contractual participation right until May 15, 2026, regarding future equity financings. The company has received a waiver from the investor for this offering.
CEO Rav Mlait announced the private placement on behalf of the Board of Directors.
This announcement does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States. The securities have not been registered under the United States Securities Act of 1933 or any U.S. state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption.
Forward-looking statements in the release are subject to risks and uncertainties.
Source: Cannabix Technologies Inc.
